We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+18.48%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$7.29B
AUM Growth
+$712M
Cap. Flow
-$287M
Cap. Flow %
-3.94%
Top 10 Hldgs %
31.93%
Holding
280
New
22
Increased
61
Reduced
163
Closed
30

Top Buys

Rank Stock Value
1
LPLA icon
LPL Financial
LPLA
+$52.3M
2
ASAN icon
Asana
ASAN
+$25.8M
3
KNF icon
Knife River
KNF
+$21.2M
4
COUR icon
Coursera
COUR
+$21M
5
MNDY icon
monday.com
MNDY
+$16.8M

Top Sells

Rank Stock Value
1
CP icon
Canadian Pacific Kansas City
CP
+$82M
2
INSP icon
Inspire Medical Systems
INSP
+$33.6M
3
TRUP icon
Trupanion
TRUP
+$32.9M
4
TSLA icon
Tesla
TSLA
+$28M
5
FND icon
Floor & Decor
FND
+$23.5M

Sector Composition

Rank Sector Weight
1 Technology 34.33%
2 Consumer Discretionary 19.26%
3 Healthcare 14.28%
4 Communication Services 12.26%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHIM icon
201
Shimmick
SHIM
$141M
$1.13M 0.02%
+171,925
New +$1.07M
OLK
202
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$1.13M 0.02%
45,109
-408,591
-90% -$9.61M
PCVX icon
203
Vaxcyte
PCVX
$8.81B
$1.07M 0.01%
17,101
-5
-0% -$260
EWCZ
204
DELISTED
European Wax Center
EWCZ
$1.04M 0.01%
76,728
+2,992
+4% +$43.3K
SLB icon
205
SLB Ltd
SLB
$79.4B
$1.03M 0.01%
19,737
-16,563
-46% -$900K
KRYS icon
206
Krystal Biotech
KRYS
$9.98B
$934K 0.01%
7,527
-1
-0% -$111
SONO icon
207
Sonos
SONO
$1.82B
$931K 0.01%
54,322
-1,799
-3% -$24.3K
RUN icon
208
Sunrun
RUN
$2.01B
$918K 0.01%
46,785
-1
-0% -$13
PATH icon
209
UiPath
PATH
$7.59B
$851K 0.01%
34,244
+3,682
+12% +$71.9K
SNAP icon
210
Snap
SNAP
$10.1B
$846K 0.01%
49,954
+5,832
+13% +$71.5K
RARE icon
211
Ultragenyx Pharmaceutical
RARE
$1.32B
$842K 0.01%
17,600
+8,008
+83% +$310K
ODD icon
212
ODDITY Tech
ODD
$844M
$836K 0.01%
+17,964
New +$608K
DISH
213
DELISTED
DISH Network Corp.
DISH
$795K 0.01%
137,700
-903,183
-87% -$4.05M
RELY icon
214
Remitly
RELY
$4.64B
$780K 0.01%
40,186
+232
+0.6% +$5.2K
RLAY icon
215
Relay Therapeutics
RLAY
$4.15B
$755K 0.01%
68,606
-63,604
-48% -$537K
VRTX icon
216
Vertex Pharmaceuticals
VRTX
$131B
$738K 0.01%
+1,814
New +$670K
COHR icon
217
Coherent
COHR
$53.9B
$683K 0.01%
15,686
-8
-0.1% -$288
WOLF icon
218
Wolfspeed
WOLF
$1.24B
$678K 0.01%
15,591
-5,041
-24% -$183K
HWM icon
219
Howmet Aerospace
HWM
$90.8B
$624K 0.01%
11,537
-2
-0% -$99
EG icon
220
Everest Group
EG
$14.5B
$603K 0.01%
1,706
-9,886
-85% -$3.83M
PODD icon
221
Insulet
PODD
$9.52B
$588K 0.01%
2,708
-9,432
-78% -$1.62M
RCKT icon
222
Rocket Pharmaceuticals
RCKT
$390M
$581K 0.01%
19,379
+475
+3% +$10.5K
GRND icon
223
Grindr
GRND
$2.68B
$579K 0.01%
65,917
+7,355
+13% +$49.7K
TNDM icon
224
Tandem Diabetes Care
TNDM
$1.15B
$535K 0.01%
+18,076
New +$375K
EVRI
225
DELISTED
Everi Holdings
EVRI
$469K 0.01%
41,627
-448,760
-92% -$5.06M
7 8
9
10 11

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Gilder Gagnon Howe & Co held 280 positions worth $7.29B, up 11% from $6.57B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $287M in Q4 2023, closing 30 positions and reducing 163 holdings. Its most notable exit was Amylyx Pharmaceuticals, an estimated $12.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Asana worth $25.2M.

  • Gilder Gagnon Howe & Co's largest Q4 2023 buy was Asana: 1,328,019 shares worth $25.2M.
  • Gilder Gagnon Howe & Co added most to LPL Financial in Q4 2023, an estimated $52.3M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2023 reduction was Canadian Pacific Kansas City, cutting an estimated $82M.
  • Gilder Gagnon Howe & Co fully exited Amylyx Pharmaceuticals in Q4 2023, selling an estimated $12.6M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 32% of its $7.29B portfolio in Q4 2023.
  • Gilder Gagnon Howe & Co opened 22 new positions and closed 30 in Q4 2023.
  • Gilder Gagnon Howe & Co's portfolio value rose 11% quarter-over-quarter to $7.29B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2023, filed 14 Feb 2024.